Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miodrag Ostojic

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 21, 2014
Glycogen phosphorylase BB in myocardial infarctionMilan Dobric, Miodrag Ostojic, Vojislav Giga, et al.
International Journal of Cardiology|March 19, 2019
Quantification of coronary artery disease using different modalities of cardiopulmonary exercise testingDejana Popovic, Marco Guazzi, Djordje G Jakovljevic, et al.
Clinical and Experimental Pharmacology & Physiology|October 31, 2015
Sustained increase in platelet aggregation after the cessation of clopidogrelNina Djukanovic, Zoran Todorovic, Danijela Zamaklar-Trifunovic, et al.
Cardiology|September 2, 2006
Outcome of patients in relation to duration of new-onset atrial fibrillation following acute myocardial infarctionMilika Asanin, Zorana Vasiljevic, Mihailo Matic, et al.
Journal of Interventional Cardiology|June 12, 2009
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI studyIgor Mrdovic, Lidija Savic, Jovan Perunicic, et al.
The Journal of Invasive Cardiology|July 7, 2010
Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology|November 23, 2011
Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
European Journal of Heart Failure|June 1, 2005
Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarctionMilika Asanin, Jovan Perunicic, Igor Mrdovic, et al.
Medical Archives (Sarajevo, Bosnia and Herzegovina)|May 18, 2019
Pharmacological Prophylaxis of Atrial Fibrillation After Surgical Myocardial RevascularizationEnes Osmanovic, Miodrag Ostojic, Sevleta Avdic, et al.
Thescientificworldjournal|October 6, 2009
In-hospital and long-term prognosis after myocardial infarction in patients with prior coronary artery bypass surgery; 19-year experiencePredrag M Mitrovic, Branislav Stefanovic, Zorana Vasiljevic, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 21, 2014
Glycogen phosphorylase BB in myocardial infarctionMilan Dobric, Miodrag Ostojic, Vojislav Giga, et al.
International Journal of Cardiology|March 19, 2019
Quantification of coronary artery disease using different modalities of cardiopulmonary exercise testingDejana Popovic, Marco Guazzi, Djordje G Jakovljevic, et al.
Clinical and Experimental Pharmacology & Physiology|October 31, 2015
Sustained increase in platelet aggregation after the cessation of clopidogrelNina Djukanovic, Zoran Todorovic, Danijela Zamaklar-Trifunovic, et al.
Cardiology|September 2, 2006
Outcome of patients in relation to duration of new-onset atrial fibrillation following acute myocardial infarctionMilika Asanin, Zorana Vasiljevic, Mihailo Matic, et al.
Journal of Interventional Cardiology|June 12, 2009
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI studyIgor Mrdovic, Lidija Savic, Jovan Perunicic, et al.
The Journal of Invasive Cardiology|July 7, 2010
Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology|November 23, 2011
Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
European Journal of Heart Failure|June 1, 2005
Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarctionMilika Asanin, Jovan Perunicic, Igor Mrdovic, et al.
Medical Archives (Sarajevo, Bosnia and Herzegovina)|May 18, 2019
Pharmacological Prophylaxis of Atrial Fibrillation After Surgical Myocardial RevascularizationEnes Osmanovic, Miodrag Ostojic, Sevleta Avdic, et al.
Thescientificworldjournal|October 6, 2009
In-hospital and long-term prognosis after myocardial infarction in patients with prior coronary artery bypass surgery; 19-year experiencePredrag M Mitrovic, Branislav Stefanovic, Zorana Vasiljevic, et al.
Pageof 11